Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial.
Tinoco, Juan Carlos
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial. [electronic resource] - Vaccine Mar 2014 - 1480-7 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2014.01.022 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral--blood
Antibody Formation
Double-Blind Method
Female
Hemagglutination Inhibition Tests
Humans
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H3N2 Subtype
Influenza B virus
Influenza Vaccines--classification
Influenza, Human--prevention & control
Male
Middle Aged
Vaccines, Inactivated--therapeutic use
Young Adult
Immunogenicity, reactogenicity, and safety of inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine in healthy adults aged ≥18 years: a phase III, randomized trial. [electronic resource] - Vaccine Mar 2014 - 1480-7 p. digital
Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
1873-2518
10.1016/j.vaccine.2014.01.022 doi
Adolescent
Adult
Aged
Aged, 80 and over
Antibodies, Viral--blood
Antibody Formation
Double-Blind Method
Female
Hemagglutination Inhibition Tests
Humans
Influenza A Virus, H1N1 Subtype
Influenza A Virus, H3N2 Subtype
Influenza B virus
Influenza Vaccines--classification
Influenza, Human--prevention & control
Male
Middle Aged
Vaccines, Inactivated--therapeutic use
Young Adult